Innoviva, Inc.
INVA
$17.21
-$0.08-0.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 116.98M | 107.37M | 88.62M | 71.19M | 71.62M |
| Total Other Revenue | 241.73M | 245.38M | 241.88M | 240.40M | 238.85M |
| Total Revenue | 358.71M | 352.75M | 330.50M | 311.59M | 310.46M |
| Cost of Revenue | 54.80M | 73.97M | 74.21M | 87.14M | 95.23M |
| Gross Profit | 303.91M | 278.77M | 256.29M | 224.45M | 215.23M |
| SG&A Expenses | 115.69M | 110.68M | 113.10M | 108.90M | 98.23M |
| Depreciation & Amortization | 25.90M | 25.90M | 25.90M | 24.42M | 21.78M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 190.13M | 183.51M | 186.55M | 193.81M | 188.59M |
| Operating Income | 168.59M | 169.24M | 143.94M | 117.78M | 121.87M |
| Income Before Tax | 37.39M | 73.90M | 153.00M | 198.08M | 194.10M |
| Income Tax Expenses | 14.00M | 9.30M | 7.57M | 16.69M | 14.38M |
| Earnings from Continuing Operations | 23.39 | 64.59 | 145.42 | 181.39 | 179.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.39M | 64.59M | 145.42M | 181.39M | 179.72M |
| EBIT | 168.59M | 169.24M | 143.94M | 117.78M | 121.87M |
| EBITDA | 194.62M | 195.27M | 169.97M | 142.33M | 143.75M |
| EPS Basic | 0.37 | 1.01 | 2.25 | 2.83 | 2.76 |
| Normalized Basic EPS | 1.62 | 1.59 | 1.33 | 1.06 | 1.09 |
| EPS Diluted | 0.21 | 0.69 | 1.65 | 2.23 | 2.18 |
| Normalized Diluted EPS | 1.44 | 1.42 | 1.13 | 0.86 | 0.88 |
| Average Basic Shares Outstanding | 250.91M | 251.99M | 254.37M | 257.19M | 261.79M |
| Average Diluted Shares Outstanding | 294.21M | 295.00M | 318.22M | 321.18M | 326.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
